Increased rates of diabetes and an aging population are driving the small joint and bone market to be one of the fastest growing fields in the orthopedic industry. Within this market, the foot and ankle device market will be one of the most rapidly increasing, growing at double-digit rates through 2017.

 

In 2010, diabetes affected 25.8 million people or approximately 8.3% of the U.S. population. The incidence of diabetes is a significant driver for foot/ankle surgery, and tends to increase with obesity and with age. As a result, incidence of this disease is expected to rise as the baby-boomer demographic ages. Diabetes has a deleterious effect on distal extremities due to the damage it causes to the quality of the body’s circulation. The feet, being distal weight-bearing parts of the body, are prone to ulcers, sores and infection. The incidence of osteoarthritis also rises as the average age of the population increases, thus driving the small bone and joint device market.